Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.94
|
2.15
|
1.98
|
1.92
|
2.00
|
1.94
|
|
|
121 004.51
|
356.00
|
1.95
|
2.03
|
2.02
|
1.96
|
2.02
|
1.98
|
|
|
112 999.61
|
350.00
|
1.96
|
2.10
|
1.98
|
1.9411
|
2.05
|
1.98
|
|
|
221 856.38
|
598.00
|
1.97
|
2.17
|
2.01
|
1.95
|
2.0599
|
2.00
|
|
|
267 960.95
|
825.00
|
1.96
|
2.17
|
2.06
|
1.98
|
2.06
|
2.00
|
|
|
218 799.46
|
628.00
|
2.00
|
2.03
|
2.09
|
2.00
|
2.13
|
2.03
|
|
|
175 588.59
|
486.00
|
2.00
|
2.26
|
2.08
|
1.98
|
2.14
|
2.14
|
|
|
247 610.70
|
616.00
|
1.97
|
2.10
|
2.09
|
1.96
|
2.125
|
2.08
|
|
|
243 490.24
|
715.00
|
2.05
|
2.23
|
2.12
|
2.03
|
2.23
|
2.05
|
|
|
183 426.58
|
720.00
|
2.13
|
2.29
|
2.19
|
2.10
|
2.26
|
2.13
|
|
|
175 210.60
|
695.00
|
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs known as selective translation regulator inhibitors (STRIs).